Drug · DIN 02478765
PANHEMATIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 5, 2018; first marketed December 5, 2018.
- Drug Identification Number (DIN)
- 02478765
- Company (DIN owner)
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Hematin B06AB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HEMIN | 268 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 13, 2018: NOC 21075New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “panhematin”. A notice may cover another product or only some lots: read it to see what it covers.
- Panhematin powder for solution: Sterility concernSeptember 13, 2024 · Biologic or vaccine · Product quality · Type I